TAOX

1.55010.40%
AJ

Alan J. Tuchman

Chief Medical Officer

Dr. Alan J. Tuchman M.D., MBA(FAAN), served as the Chief Executive Officer at TAO Synergies Inc. (formerly known as Synaptogenix, Inc.) (formerly, Neurotrope Bioscience, Inc.), from December 2020 to June 8, 2025 and had been its Director since December 02, 2020 until August 28, 2025 and serves as its Chief Medical Officer. He served as Acting Chief Medical Officer at Neurotrope, Inc. Dr. Tuchman served as the Chief Neuro Oncology Research Officer of Oncolytics Biotech Inc. since October 31, 2016 until July 6, 2017 served as its Senior Vice President and Chief Medical Officer from 2012 to 2017. He serves as a Principal at NeuroPhysics Corporation. Dr. Tuchman serves as a Partner at Xmark Opportunity Partners, LLC and served as its Chief Executive Officer and then Executive Chairman of Neurophysics, Incorporated from 2002 to 2010. He serves as Clinical Professor of Neurology and Pharmacology at New York Medical College. Dr. Tuchman served as Chief Medical Officer and Senior Vice President of Medical & Clinical Affairs at Oncolytics Biotech Inc. since September 27, 2012 until November 10, 2016 and served as its Senior Vice President of Clinical & Medical Development since September 27, 2012. From 2002 to 2003, Dr. Tuchman served as the Chief Executive Officer at Neurophysics. From 2005 to 2006, he served as Managing Director at Xmark Capital Partners. From 2002 to 2004, Dr. Tuchman served as a Principal of Xmark Funds, New York. He served as an Equity Analyst at Oscar Gruss and Son Inc., Research Division. From 1997 to 2001, he served as the Senior Vice President of Equity Research at Oscar Gruss & Son, where he conducted investment research and helped develop marketing strategies for healthcare companies. He served as the President of the Epilepsy Society of Southern New York as well as Vice Dean for Clinical Affairs at New York Medical College. Dr. Tuchman founded and was Managing Director of MedPro Investors Limited Liability Company from 2011 to 2020. He served Senior Neurology positions at New York Medical College and Lincoln Medical and Mental Health Center. He serves as Executive Chairman of Neurophysics, Inc. He has been a Director of Cordex Pharma, Inc. since October 2007. He serves as a Member of Scientific Advisory Board at MultiCell Technologies, Inc. He served as a Member of Scientific Advisory Board at Oncolytics Biotech Inc. He completed his Neurology Residency at the Mt Sinai School of Medicine. He serves as a Member of Xmark Asset Management LLC. Dr. Tuchman served as a Director of Aeolus Pharmaceuticals, Inc. from April 30, 2004 to June 30, 2004. Dr. Tuchman is the author of over 30 scientific papers and book chapters. He received his Medical Degree from the University of Cincinnati, College of Medicine in 1972 and completed his Neurology Residency at the Mt. Sinai School of Medicine. Dr. Tuchman received his M.B.A. from Columbia University in 1996. He holds BS in Chemistry from The City College of New York in 1968.

Positions